Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis
Fig 5
Kaplan-Meier (re-)bleeding curves with NSBB and comedication (statin, metformin or RASi) or non-comedication for primary and secondary prophylaxis.